Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
BIOMARKER:
VTCN1 overexpression
i
Other names:
VTCN1, V-Set Domain Containing T Cell Activation Inhibitor 1, B7-H4, B7H4, B7S1, V-Set Domain-Containing T-Cell Activation Inhibitor 1, Immune Costimulatory Protein B7-H4, B7 Superfamily Member 1, B7 Family Member, H4, B7 Homolog 4, FLJ22418, B7h.5, B7x, T Cell Costimulatory Molecule B7x, T-Cell Costimulatory Molecule B7x, Protein B7S1, PRO1291, VCTN1, B7X
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
79679
Related biomarkers:
Expression
Others
‹
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
VTCN1 overexpression
Bladder Cancer
VTCN1 overexpression
Bladder Cancer
cisplatin
Sensitive: C3 – Early Trials
cisplatin
Sensitive
:
C3
cisplatin
Sensitive: C3 – Early Trials
cisplatin
Sensitive
:
C3
VTCN1 overexpression
Bladder Cancer
VTCN1 overexpression
Bladder Cancer
PD-L1 inhibitor
Sensitive: C3 – Early Trials
PD-L1 inhibitor
Sensitive
:
C3
PD-L1 inhibitor
Sensitive: C3 – Early Trials
PD-L1 inhibitor
Sensitive
:
C3
VTCN1 overexpression
Solid Tumor
VTCN1 overexpression
Solid Tumor
GEN1047
Sensitive: D – Preclinical
GEN1047
Sensitive
:
D
GEN1047
Sensitive: D – Preclinical
GEN1047
Sensitive
:
D
VTCN1 overexpression
Solid Tumor
VTCN1 overexpression
Solid Tumor
PF-08046048
Sensitive: D – Preclinical
PF-08046048
Sensitive
:
D
PF-08046048
Sensitive: D – Preclinical
PF-08046048
Sensitive
:
D
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.